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Vasodilation of lower leg arterioles is impaired in animal models of chronic peripheral
ischemia. In addition to arterioles, feed arteries are a critical component of the vascu-
lar resistance network, accounting for as much as 50% of the pressure drop across the
arterial circulation. Despite the critical importance of feed arteries in blood ﬂow control,
the impact of ischemia on feed artery vascular reactivity is unknown. At 14 days following
unilateral resection of the femoral–saphenous artery–vein pair, functional vasodilation of
the profunda femoris artery was severely impaired, 11± 9 versus 152± 22%. Although
endothelial and smooth muscle-dependent vasodilation were both impaired in ischemic
arteries compared to control arteries (Ach: 40± 14 versus 81± 11%, SNP: 43± 12 ver-
sus and 85± 11%), the responses to acetylcholine and sodium nitroprusside were similar,
implicating impaired smooth muscle-dependent vasodilation. Conversely, vasoconstriction
responses to norepinephrine were not different between ischemic and control arteries,
−68± 3 versus −66± 3%, indicating that smooth muscle cells were functional following
the ischemic insult. Finally,maximal dilation responses to acetylcholine, ex vivo, were signif-
icantly impaired in the ischemic artery compared to control, 71± 9 versus 97± 2%, despite
a similar generation ofmyogenic tone to the same intravascular pressure (80mmHg).These
data indicate that ischemia impairs feed artery vasodilation by impairing the responsiveness
of the vascular wall to vasodilating stimuli. Future studies to examine the mechanistic basis
for the impact of ischemia on vascular reactivity or treatment strategies to improve vascu-
lar reactivity following ischemia could provide the foundation for an alternative therapeutic
paradigm for peripheral arterial occlusive disease.
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INTRODUCTION
The most common symptom in patients with peripheral arterial
occlusive disease (PAOD) is intermittent claudication, an ischemic
pain during locomotion or exercise (Aronow, 2005). Intermittent
claudication is typically explained by poorly developed collater-
als in PAOD patients (Ziegler et al., 2010), which is supported
by the observation that exercise training in animal models of
chronic peripheral ischemia improves exercise capacity (Yang et al.,
1990) and induces arteriogenesis (Yang et al., 2008). However, the
lack of correlation between the ankle-brachial index (a ratio of
ankle and brachial arterial pressures) and physical performance in
patients suggests that structural deﬁcits are not sufﬁcient to explain
reduced limb function and the onset of intermittent claudication
with PAOD (Coutinho et al., 2011). An alternative explanation is
that intermittent claudication is caused, or at least exacerbated,
by poor vascular reactivity. Patients that experience intermittent
claudication have sufﬁcient muscle perfusion at rest, but experi-
ence ischemic pain at a time when functional vasodilation would
be expected to induce hyperemia and increase oxygen delivery
to contracting muscle, a phenotype that can be recapitulated in
rodent models (Brevetti et al., 2001). Additional support for the
hypothesis that intermittent claudication is caused, or affected, by
impaired vascular reactivity, can be found in the observation that
exercise training increases walking distance and improves vascular
reactivity in patients with PAOD (Brendle et al., 2001) and ani-
mal models of chronic peripheral ischemia (Hudlicka et al., 1994;
Kelsall et al., 2004).
The possibility that impaired vascular reactivity plays a causal
role in the pathophysiology of PAOD warrants investigation into
the impact of arterial occlusion on resistance vessel reactivity.
Understanding the mechanism of impaired vascular reactivity
with chronic peripheral ischemia could provide the foundational
knowledge for a new paradigm in the treatment of PAOD. Most
effort in this area has been directed toward examining perfu-
sion through the collateral circuit (Yang et al., 1990; Colleran
et al., 2010), which is the primary site of resistance to blood
ﬂow in the distal ischemic zone (Taylor et al., 2008a). However,
the collateral circuit is not the only signiﬁcant site of resistance
in the ischemic hindlimb. Perfusion in the distal hindlimb of
Rac2−/− and Nox2−/− mice is reduced despite normal collateral
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enlargement (Distasi et al., 2009), suggesting that the resistance
vasculature in the ischemic zone makes a signiﬁcant contribution
to the overall resistance to blood ﬂow. This is further supported by
computational studies indicating that vasodilation, angiogenesis,
capillary arterialization, and collateral enlargement are necessary
to explain perfusion recovery following unilateral ligation of the
femoral artery (Benedict, Experimental Biology, 2011).
Although numerous reports have examined the impact of
chronic ischemia on regional blood ﬂow (Bauters et al., 1995;
Walder et al., 1996; Yang et al., 1996; Song et al., 2004), it
is difﬁcult to discern the relative impacts of vascular architec-
ture (i.e., enhanced arteriogenesis) and vascular reactivity (i.e.,
improved vasodilation) when measuring whole muscle or entire
limb blood ﬂow. Therefore, determining the impact of chronic
ischemia on vascular reactivity requires measuring response in
individual arterioles and feed arteries, each of which contributes
approximately 50% of the overall resistance to tissue blood ﬂow
(Lash, 1994; Segal, 2000; Sweeney et al., 2007). In rat models of
chronic peripheral ischemia, arterioles of the lower leg exhibit
impaired functional (Dawson et al., 1990; Hudlicka et al., 1994)
and endothelial-dependent vasodilation at early time points and
impaired smooth muscle-dependent vasodilation at late time
points (Kelsall et al., 2001). Reactivity of angiographically iden-
tiﬁable arterial vessels in the ischemic rat hindlimb demon-
strate impaired endothelial- (Takeshita et al., 1998) and smooth
muscle-dependent vasodilation (Takeshita et al., 1997), but the
location of these vessels in the hindlimb vascular circuit can-
not be readily determined. The impact of chronic ischemia on
vascular reactivity of feed arteries has only been assessed ex
vivo (Taylor et al., 2008b). In these studies, feed artery reactiv-
ity to endothelial- and smooth muscle-dependent dilators was
unaffected by ischemia, even when examined at low and high
intraluminal pressures (Taylor et al., 2008b). The divergence of
observations regarding the impact of ischemia on arterioles and
feed arteries, ex vivo and in vivo warrants further investiga-
tion into the impact of chronic ischemia on vascular reactivity.
Even though the collateral circuit is the primary site of resis-
tance in the ischemic hindlimb, the critical role of feed arteries
in blood ﬂow control suggests that improving vascular reactiv-
ity in patients with PAOD will require functional restoration of
intramuscular arterioles and resistance arteries in the ischemic
zone.
To test the hypothesis that ischemia impairs vasodilation in feed
arteries,we assessed functional vasodilation and vascular reactivity
(in vivo and ex vivo) in the profunda femoris artery (aka muscu-
lar branch) at day-14 following unilateral resection of the femoral
artery and vein in the mouse hindlimb.
MATERIALS AND METHODS
ANIMALS
Male and female C57Bl/6 or C57Bl/6 hybrid mice (SW-129SV)
were used for all experiments between 2 and 4months of age,
according to protocols approved by the University of Arizona
and Cal Poly State University Institutional Animal Care and Use
Committees. Male and female hybrid mice were used for the ex
vivo vascular reactivity experiments. The control group included
three animals one male and two females. The experimental group
included six animals four males and two females. C57 male mice
were used for all of the in vivo studies, with eight mice per group.
C57Bl/6 hybrid mice were obtained from a breeding colony main-
tained at the University of Arizona while C57Bl/6 mice were
obtained from Taconic Farms. Mice were maintained on a 12:12-h
light:dark cycle and given water and rodent chow ad libitum.
CHRONIC HINDLIMB ISCHEMIA SURGERY
Chronic hindlimb ischemia was induced by unilateral ligation and
resection of the left femoral and saphenous artery–vein pair, from
∼2mm upstream to the profunda femoris artery (aka muscu-
lar branch) to halfway between the knee and ankle, as described
(Coufﬁnhal et al., 1998; Sullivan et al., 2002) with some mod-
iﬁcations. Animals were anesthetized in an induction chamber
with 5% isoﬂurane administered through an isoﬂurane vapor-
izer and balanced with oxygen ﬂowing at ∼3.5 l ·min−1. Fol-
lowing induction, anesthesia was maintained throughout animal
preparation and surgery with 1–2% isoﬂurane balanced with
oxygen ﬂowing at 0.5–1.0 l ·min−1 though an anesthesia mask.
Prior to surgery, left hindlimb hair was removed with trimming
clippers and depilatory cream and rubbed with chlorhexidine
diacetate to disinfect. Animals were maintained at ∼35˚C with
a rectal-temperature-controlled heat pad (TR-200, FST, Foster
City, CA, USA). The epigastric neurovascular bundle and fat
pad were dissected free with a heat cautery to create access for
the upstream ligation site. Following resection of the artery–
vein pair, the skin incision was closed with 7-0 polypropylene
suture. Animals were given buprenorphine as an analgesic subcu-
taneously at a dose of 0.075mg kg−1 and allowed to recover with
warming.
FUNCTIONAL VASODILATION
At day-14 following the hindlimb ischemia surgery, animals were
anesthetized and prepared as described above; a skin incision and
gentle blunt dissection were used to expose the profunda femoris
artery. A tungsten stimulating electrode (1–5μm tip diameter and
250μm shaft diameter, FHC, Bowdoinham,ME, USA) was rested
across themid-belly (approximate location of themotor endplate)
of the gracilis muscles; the ground electrode was placed subcuta-
neously at the periphery of the incision and a brief set of con-
tractions was induced to conﬁrm proper electrode placement. The
exposed tissue was covered with mineral oil to prevent desiccation
and minimize oxygen exchange (Young et al., 1986). The intrav-
ital microscope (Microscan, Microvision Medical, Amsterdam,
Netherlands) was then placed over the distal profunda femoris
(the ﬁeld of view was immediately anterior to the gracilis anterior
muscle), electrode placement was evaluated a second time, and
the preparationwas given 30min to stabilize beforemeasurements
were made. To elicit functional vasodilation, the gracilis muscles
were stimulatedwith 1mA squarewaves of 0.2ms duration at 8Hz
for 90 s using a stimulus isolator and PowerLab 4-channel data
acquisition system (ADInstruments,Colorado Springs,CO,USA).
Profunda diameters were determined from merged still frames of
videos of the microscope ﬁeld using Automated Vascular Analy-
sis (Microvision Medical, Amsterdam, Netherlands). To account
for animal-to-animal variation in baseline artery diameter, resting
diameter was set to 0%; increases above 0% represent vasodilation.
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IN VIVO VASCULAR REACTIVITY
At day-14 following the hindlimb ischemia surgery, animals were
anesthetized and prepared as described above. The intravital
microscope was placed over the profunda femoris and the exposed
tissue was continually irrigated with a physiological salt solution
(PSS) that contained (in mM) NaCl 137, KCl 4.7, MgSO4 1.2,
CaCaL2 2, NaHCO3 18, and was bubbled with 5% CO2-95% N2.
The PSS was maintained at ∼35˚C and ﬂowed over the muscle at
∼2mlmin−1, as described previously (Moore et al., 2010). The
preparation was given 30min to stabilize before the application of
vasoactive agents. For the ﬁrst study, increasing doses of Ach were
applied to generate a dose response curve, prior to application of
SNP. In the second study, maximal doses of the vasoactive agents
were applied in the following order (all at 10−4 M): norepineph-
rine, acetylcholine, and sodium nitroprusside. Profunda diameter
was given 5min to stabilize between the application of the each
pharmacological agent. Diameter measurements were obtained as
described above. Decreases below 0% represent vasoconstriction.
EX VIVO VASCULAR REACTIVITY
At day-14 following the hindlimb ischemia surgery, animals were
anesthetized and prepared as described above. The distal aspect
of the profunda femoris artery, running deep to the gracilis ante-
rior muscle, was dissected from the ischemic hindlimb and non-
ischemic contralateral hindlimb, or from a non-ischemic control,
as described (Sun et al., 1994). Following dissection, the feed
artery was cleaned of connective tissue in a PSS solution main-
tained below 10˚C. PSS was composed of the following (in mM)
119 NaCl, 4.7 KCl, 1.2 MgSO4, 1.7 KH2PO4, 1.6 CaCl, 5 glu-
cose, and 18 NaHCO3. Cleaned arteries were cannulated and
prepared for microscopic viewing, as described (Kurjiaka et al.,
2005). The cannulated vessel was then warmed to 35˚C and pres-
surized to 80mmHg to induce myogenic tone development prior
to the application of acetylcholine (Ach) in PSS. Vessels were
warmed to 35˚C, as opposed to 37–38˚C because the distal pro-
funda femoris arteries used in these studies were isolated from
the peripheral skeletal muscle, which at rest is less than core-body
temperature, and tends to be closer to 34–35˚. Following collec-
tion of dose response curves to Ach, Ca+2-free PBS with 3mM
EGTA was applied to obtain the maximal passive diameter. To
account for animal-to-animal variation in baseline artery diam-
eter, all diameter measurements were ﬁt within a scale ranging
from 0% (myogenic tone) to 100% (maximal passive diameter)
for statistical analysis and graphic display.
STATISTICS
Data are presented as mean± SEM. Statistical signiﬁcance was set
at p ≤ 0.05. Differences in maximal profunda functional vasodila-
tion were assessed by paired t -test. Differences in in vivo profunda
reactivity were assessed by one-wayANOVA, followed by Student’s
t -tests. Differences in functional vasodilation recovery and ex vivo
profunda reactivity were assessed by repeated measures ANOVA
followed by Student’s t -tests. EC50 values were obtained using the
non-linear regression procedure in SAS.
RESULTS
FUNCTIONAL VASODILATION IN THE ISCHEMIC PROFUNDA
To determine if ischemia impaired endogenous vasodilation path-
ways, we measured the diameter of the profunda femoris feed
artery before and after electrical stimulation of gracilis mus-
cle contraction, Figures 1A,B. Ischemia signiﬁcantly increased
the resting diameter in the profunda femoris, 76± 4 versus
50± 4μm. However, the increase in resting diameter did not
reﬂect amaximal dilation, and ischemia profoundly reduced func-
tional vasodilation in the profunda femoris, which exhibited an
11± 9% increase above resting diameter immediately following
gracilis muscle contraction, compared to a 152± 22% increase
in the profunda from the contralateral, sham operated limb,
Figures 1C,D.
IN VIVO VASCULAR REACTIVITY IN THE ISCHEMIC PROFUNDA
Next, we tested the hypothesis that impaired functional vasodi-
lation following ischemia could be explained by endothelial
FIGURE 1 | Intravital microscopy imaging field and functional
vasodilation responses in the profunda femoris arteries, in vivo. (A)
Representative photomicrographs of the distal profunda femoris
artery–vein pair imaging site for functional vasodilation and vascular
reactivity studies at rest and (B) immediately following the cessation of
8Hz muscle contraction. (C) Resting diameter and 10min following 90 s of
8Hz muscle contraction in day-14 ischemic (gray circles) and contralateral
control (black boxes) profunda femoris arteries. (D) Maximal functional
vasodilation in day-14 ischemic (gray) and contralateral control (black)
profunda femoris arteries following 90 s of 8Hz muscle contraction. Data
points are on a relative scale, with resting diameter represented by 0%.
∗p ≤0.05 versus day-14 ischemic.
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dysfunction. To test this hypothesis, we measured the diameter
of the profunda femoris feed artery before and after application of
acetylcholine (Ach) and sodiumnitroprusside (SNP), endothelial-
and smooth muscle-dependent vasodilators, respectively. In the
ﬁrst study, we generated dose response curves to Ach (10−8–10−4)
prior to the application of SNP (10−4). In this study, resting diam-
eter was signiﬁcantly larger in ischemic than non-ischemic vessels,
116± 11 versus 80± 6μm, respectively. However, ischemia sig-
niﬁcantly reduced vascular reactivity, as percent increase in artery
diameter was signiﬁcantly lower at 10−6 (22± 6 versus 53± 12%),
10−5 (24± 7 versus 65± 11%), and 10−4 M Ach (25± 7 versus
69± 11%), Figure 2A. EC50 was not different between ischemic
and control vessels, 2.55× 10−7 versus 1.62× 10−7 MAch, respec-
tively, but only seven non-ischemic and four ischemic replicates
were able to achieve convergence in the non-linear regression
model. Dilation responses to SNP were also signiﬁcantly reduced
in the ischemic artery as compared to the control artery, 31± 7 ver-
sus 72± 11%, respectively. To ensure that the reduced reactivity of
the ischemic vessels was not due to the increased resting diameter
of the profunda femoris, we completed a second study in which
we delivered maximal doses of Ach (10−4) and SNP (10−4). In
these animals, resting diameter was not different between ischemic
and non-ischemic vessels, 82± 10 versus 76± 6μm, respectively.
Ischemia still signiﬁcantly reduced vasodilation following the
application of Ach, 40± 14 versus 81± 11%. The roughly 50%
reduction in vasodilation to Ach was mirrored by the responsive-
ness to SNP, which was 43± 12% in the ischemic artery versus
85± 11% in the control, Figure 2B. Although there was a signiﬁ-
cant reduction in vasodilation responses in the ischemic arteries,
there was no difference between the response to acetylcholine and
sodium nitroprusside in either study.
To complete our in vivo studies, we tested the hypothesis that
the reduction in smoothmuscle-dependent vasodilation could not
be explained by a generalized loss of smooth muscle function. To
test this hypothesis,we ﬁrst performed a pilot study to examine the
dose response to norepinephrine (NE), Figure 3A. Based on the
pilot data, we measured the diameter of the profunda femoris
feed artery before and after application of a maximal dose of
NE (10−4 M). Ischemia had no effect on norepinephrine-induced
vasoconstriction in the profunda femoris artery, as demonstrated
by a similar decrease in diameter compared to the contralateral
artery, 26± 4 versus 25± 1μm, Figure 3B. These responses rep-
resent a 66± 3 and 68± 3% decrease from resting diameters in
the ischemic and non-ischemic vessels, respectively, which were
not different.
EX VIVO VASODILATION IN THE ISCHEMIC PROFUNDA
Given that intravascular pressure in the profunda femoris is
likely decreased by the femoral artery–vein resection, we tested
the hypothesis that reduced arterial pressure could explain the
reduced vascular reactivity in this vessel. To test this hypothesis,
we measured the diameter response to acetylcholine (Ach) in iso-
lated, distal profunda femoris arteries that were pressurized to the
approximate pressure of the control profunda. Resting diameter
was signiﬁcantly larger in the ischemic profunda, 105± 6 versus
62± 3μm. Given the individual variations in resting diameter, ex
vivo artery responses were expressed as a percent change, with
FIGURE 2 |Vasodilation responses to endothelial- and smooth
muscle-dependent dilating agents in ischemic and non-ischemic
profunda femoris arteries, in vivo. (A) Vasodilation responses to
increasing doses of acetylcholine (Ach), applied in 10−x M increments, and a
maximal dose of sodium nitroprusside (SNP) in day-14 ischemic (gray) and
non-ischemic (black) arteries. (B) Vasodilation responses to maximal doses
of Ach (10−4 M) and SNP (10−4 M) in day-14 ischemic (gray) and contralateral
control (black) profunda femoris arteries. Data points are on a relative scale,
with resting diameter represented by 0%. ∗p ≤0.05 versus day-14 ischemic.
0% representing myogenic tone and 100% representing maxi-
mal passive vasodilation in calcium-free conditions. Despite being
exposed to an equal hydrostatic pressure (80mmHg) and devel-
oping an equivalent level of myogenic tone (61± 5 versus 58± 1%
of maximal passive diameter), vasodilation was still signiﬁcantly
impaired in the ischemic profunda femoris artery (71± 9 versus
97± 2% of maximal diameter at 3× 10−5 MAch),Figure 4. EC50
was signiﬁcantly lower in the ischemic vessels, 2.82× 10−7 versus
8.03× 10−7 M Ach. The greater EC50 extrapolates that a higher
concentration of Ach was necessary to induce vasodilation to 50%
of themaximal response, indicating that the ischemic arteries were
less sensitive to Ach.
DISCUSSION
Patients with PAOD, who often present with intermittent clau-
dication (Aronow, 2005), exhibit impaired vasodilation (Poredos
et al., 2003), suggesting that improving vasodilation may be a rea-
sonable strategy to alleviate ischemic pain associatedwith locomo-
tion.Advancing this therapeutic paradigm requires understanding
the mechanism of impaired vasodilation with chronic ischemia.
Previous work demonstrated that chronic ischemia signiﬁcantly
impaired vasodilation in intramuscular arterioles (Hudlicka et al.,
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FIGURE 3 |Vasoconstriction responses to norepinephrine in ischemic
and non-ischemic profunda femoris arteries, in vivo. (A) Pilot study
measuring the vasoconstriction responses to increasing doses of
norepinephrine (NE), applied in 10−x M increments, and (B) vasoconstriction
responses to maximal doses of NE (10−4 M) in day-14 ischemic (gray) and
contralateral control (black) profunda femoris arteries. Data points are on a
relative scale, with resting diameter represented by 0%.
1994), but the effect of ischemia on feed arteries in vivo was
unknown. Therefore, the objective of this work was to describe the
effect of chronic ischemia on feed artery functional vasodilation
and vascular reactivity.
As expected, chronic ischemia signiﬁcantly impaired func-
tional vasodilation in the profunda femoris feed artery, Figure 1.
Given that ischemic arterioles demonstrate impaired endothelial-
dependent vasodilation (Kelsall et al., 2001), we tested the hypoth-
esis that impaired functional vasodilation in feed arteries could
be explained by reduced endothelial-dependent responses. Sur-
prisingly, both endothelial- and NO-mediated smooth muscle-
dependent vasodilation were impaired in the profunda femoris
feed artery following chronic ischemia, Figure 2.
Endothelial-dependent vasodilation was impaired in the pro-
funda femoris following ischemia, but the degree of impairment
was less than in intramuscular arterioles, which exhibit a slight
vasoconstriction in response to acetylcholine (Kelsall et al., 2001).
This reduced effect of ischemia on feed arteries, as compared to
intramuscular arterioles, could be explained by the anatomical
location of the feed arteries, which are outside of the parenchymal
tissue. Intramuscular arterioles are likely affected to a greater
FIGURE 4 | Dose response curve to acetylcholine in ischemic and
non-ischemic distal profunda femoris arteries, ex vivo. Vessels were
pressurized to 80mmHg (baseline) and developed myogenic tone before
exposure to the initial dose of Ach (10−8 M); increasing doses were applied
at 3×10−x M increments. Data points are on a relative scale, with myogenic
tone represented as 0% and maximal passive vasodilation represented as
100% (Ca+2-free PSS+EGTA). ∗p ≤0.05 versus day-14 ischemic.
extent by the hypoxia, elevatedmetabolites, and reduced pH resul-
tant from skeletal muscle activity and the inﬂammation induced
by myoﬁber repair (Scholz et al., 2002, 2003).
Even considering the explanation that feed arteries would be
less affected by the ischemic tissue environment than arterioles,
it is surprising that acetylcholine-dependent vasodilation was so
much greater than functional vasodilation in the ischemic pro-
funda, 40 versus 11% increase in diameter. In ischemic arterioles,
functional vasodilation (Hudlicka et al., 1994) and acetylcholine
(Kelsall et al., 2001) induced a slight vasoconstriction. The incon-
gruence between functional- and acetylcholine-vasodilation could
be explained by an impaired conducted response. As mentioned
above, feed arteries lie outside of the metabolic ﬁeld; therefore, the
vasodilation response stimulated by an increase in tissue metab-
olism must be transmitted along the intramuscular arteriolar
endothelium to the extra-parenchymal feed artery. If the conduc-
tion of vasodilation stimuli from the arterioles to the feed artery
were impaired, then the feed artery would be capable of respond-
ing to exogenous vasodilators even if the same vessel were relatively
unresponsive to increases in muscle metabolism. This hypothesis
is supported by the observation that in the Cx40−/− mouse, arte-
riolar vasodilation responses to acetylcholine are normal, despite
a reduction in both conducted responses (DeWit et al., 2000) and
functional vasodilation (Milkau et al., 2010).
Although chronic ischemia had a more mild effect on
endothelial-dependent vasodilation in feed arteries than on intra-
muscular arterioles (Kelsall et al., 2001), NO-mediated smooth
muscle-dependent vasodilation was signiﬁcantly impaired, and
similar to endothelial-dependent vasodilation responses,Figure 2.
Based on previous work, we expected vasodilation responses to
sodium nitroprusside to remain intact at day-14 following the
induction of chronic ischemia (Kelsall et al., 2001). This result can-
not be explained by a generalized reduction in smoothmuscle tone
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control, such as would be expected with the conversion to a syn-
thetic phenotype during a structural remodeling event (Schaper,
2009), as the profunda femoris exhibited normal vasoconstric-
tion responses to norepinephrine, Figure 3. Nor can the reduced
vascular reactivity be explained solely by a reduced perfusion pres-
sure, which would be expected following femoral artery resection,
because ischemic profunda femoris arteries exhibited reduced
vasodilation when they were isolated and pressurized to the same
level as contralateral control arteries, Figure 4. Interestingly, these
results are not without some precedent, as endothelial- and NO-
mediated smooth muscle-dependent vasodilation is impaired in
intramuscular arterioles at 5-weeks following induction of chronic
ischemia (Kelsall et al., 2001) and in angiographically identiﬁable
arteries of the rat thigh (Takeshita et al., 1997). The mechanism
of impaired NO-mediated smooth muscle-dependent responses
in these reports and in the data presented above is unknown, but
may be related to oxidative stress, which increases with chronic
ischemia (Pipinos et al., 2008) and impairs dilation responses to
both acetylcholine and sodium nitroprusside in the obese Zucker
rat (Frisbee and Stepp, 2001).
Our ﬁndings indicate that ischemia impairs the vascular
smooth muscle cell signaling pathways involved in vasodilation.
Much of the work in the area of smooth muscle-dependent tone
regulation following arterial occlusion has addressed adrenergic
signaling. Although adrenergic contractility appears to decrease
in the collateral circulation (Taylor et al., 2008b) and in distal
(ischemic) skeletal muscle arterioles (Kelsall et al., 2001) of rodent
models,α-adrenergic contractility is exaggerated in ischemic skele-
tal muscle from patients (Jarajapu et al., 2001). The difference
between rodent and patient responses is possibly due to the
increased sympathetic tone observed with advanced age (Dinenno
et al., 2005). Regardless, elevated sympathetic tone, which would
be surprising in a rodent model of ischemia, does not appear to
explain the impaired vasodilation observed in our studies, since
norepinephrine-induced vasoconstriction is not altered, Figure 3.
Although our ﬁnding appears contradictory to previous studies
(Kelsall et al., 2001; Taylor et al., 2008b), it is not surprising that
ischemia would have a limited effect on adrenergic sensitivity
of the profunda femoris, because feed arteries are typically less
sensitive to sympathetic tone than intramuscular arterioles (Van-
teeffelen and Segal, 2003), which comprise most of the collateral
circuit studied in previous reports.
Given the normal responses of ischemic arteries to norepineph-
rine (Figure 4), it would appear that ischemia speciﬁcally impairs
the signaling cascades controlling smooth muscle cell relaxation
in feed arteries. Few reports have assessed the impact of ischemia
on smooth muscle cell signaling, as it pertains to vasodilation,
but ischemia could be characterized by a reduction in NO-cGMP
signaling, as supplementation with l-arginine (Murohara et al.,
1998) or inhibition of PDE-5 increases vascular density and tissue
perfusion following ischemia (Senthilkumar et al., 2007). Oxida-
tive stress, induced by ischemia (Pipinos et al., 2008), could also
contribute to impaired NO-dependent responses.
Having only assessed NO-mediated smoothmuscle-dependent
responses, we cannot deﬁnitively conclude that ischemia induces
a generalized impairment in smooth muscle-dependent relax-
ation, as relaxation to other pathways may still be intact. Although
acetylcholine is known to cause endothelial production of NO,
prostanoid dilators, and hyperpolarizing agents (Fitzgerald et al.,
2007), it is possible that chronic ischemia impairs endothelial pro-
duction of dilating arachidonic acid derivatives without affecting
their smoothmuscle cell receptors.However, limited evidence sug-
gests that chronic ischemiamay also alter hyperpolarizing-channel
function in feed arteries, as ischemia-reperfusion injury increases
the sensitivity of calcium-activated potassium channels, or BK
channels (Woodman andWongsawatkul, 2004). Therefore, future
studies are necessary to dissect the impact of chronic ischemia
on the myriad of pathways capable of causing smooth muscle
relaxation. This effort is challenged by the fact that a paracrine
factor(s) has not been demonstrated to be both necessary and
sufﬁcient for functional vasodilation (Clifford and Hellsten, 2004;
Segal, 2005), but the endothelium appears to be critical for the
response (Duza and Sarelius, 2004), so future workwould focus on
the impact of ischemia on pathways involving endothelial-derived
factors. Speciﬁcally, the functionality prostanoid-dependent dila-
tion would be assessed by applying arachidonic acid to assess the
functionality of the endothelial cylcooxygenase cascade (Frisbee
et al., 2009), while a prostacyclin analog, such as iloprost, would
be used to assess the functionality of smooth muscle receptors
(Frisbee, 2004).Assessing the functional status of hyperpolarizing-
dependent dilation is of greater difﬁculty, owing to the large
number of factors apparently capable of inducing smooth mus-
cle hyperpolarization (Feletou and Vanhoutte, 2006), and would
therefore likely involve assessing the impact of potassium channel
inhibitors on vasodilation responses to factors that are known to
induce hyperpolarization, such as acetylcholine.
Our ﬁndings implicating smooth muscle dysfunction in
impaired vascular reactivity with chronic ischemia may seem
incongruent with preclinical (Bauters et al., 1995; Takeshita et al.,
1998; Kelsall et al., 2004) and clinical reports (Poredos et al.,
2003; Coutinho et al., 2011) that implicate endothelial dysfunc-
tion as the cause of impaired vascular reactivity. This incon-
gruence could be explained in several ways. First, feed arter-
ies may be differentially affected by ischemia than intramus-
cular arterioles, which exhibit impaired endothelial-dependent
responses at day-14 following arterial occlusion (Kelsall et al.,
2004). Support for this explanation comes from the observa-
tion that in patients, conduit vessels exhibit impaired endothelial-
and smooth muscle-dependent responses, while resistance vessels
exhibit only impaired endothelial-dependent responses (Liao et al.,
1991). Second, the efﬁcacy of endothelial-derived relaxing fac-
tors is dependent on the functionality of vascular smooth muscle
cells. Therefore, deﬁning endothelial dysfunction should require
the observation of impaired endothelial-dependent dilation and
intact smooth muscle-dependent dilation. However it is common
in preclinical reports to conclude endothelial dysfunction after
the application of only endothelial-dependent agents (Bauters
et al., 1995; Takeshita et al., 1998) or in clinical reports based
solely on ﬂow-mediated dilation responses (Poredos et al., 2003).
Finally, observations of endothelial dysfunction in patients could
be explained by common co-morbidities to ischemic disease rather
than the ischemic insult itself. For example, hypercholesterolemia
and hyperglycemia are known to induce endothelial dysfunction
(Granger et al., 2010; Ziegler et al., 2010).
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One of the potential limitations of this study is the inclusion
of C57Bl/6 hybrid mice of both sexes for the ex vivo vascular
reactivity study. Although the variation in the study is small,
and the ﬁndings are consistent with the in vivo studies that uti-
lized only male C57Bl/6 mice, the data could not be stratiﬁed on
the basis of sex and strain. Therefore, the absence of strain and
sex-speciﬁc inﬂuences on the vascular response to ischemia can-
not be conﬁrmed, suggesting some caution when interpreting the
ﬁndings.
In summary, the aim of these studies was to describe the impact
of chronic ischemia on feed artery vascular reactivity. Feed artery
functional vasodilation is severely impaired by chronic ischemia.
The mechanism of this impairment cannot be explained by a sim-
ple reduction in intravascular pressure and appears to be due to
impaired smooth muscle relaxation pathways. Interestingly, path-
ways controlling smooth muscle cell contraction remain intact.
The dysfunctional signaling elements in smoothmuscle relaxation
will be identiﬁed in subsequent investigations. This overall area of
research, determining the cellular basis for the impact of chronic
ischemia on resistance vessel reactivity, has the potential to form
the foundation for a new therapeutic paradigm in the treatment
of PAOD.
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